Welcome Guest

U.S. FDA approves AstraZeneca diabetes drug for treating heart failure risk

reuters | Posted on 2019-10-21 12:36 PM

AstraZeneca's diabetes drug Farxiga has been approved for use in the United States as a treatment to reduce the chances of hospitalisation for heart failure in adults with type-2 diabetes and other cardiovascular risks, the British drugmaker said on Monday.

Related Articles

  • Live
  • Upcomming
  • Completed